Posted on 04/09/202404/09/2024 by ScienceFather 58 / 100 Powered by Rank Math SEO SEO Score Prof Dr. Laura Evangelista | Medicine Nuclear | Best Researcher Award Full Professor at Humanities University, Italy Dr. Laura Evangelista is a distinguished Nuclear Medicine physician and researcher, currently serving as an Extraordinary Professor and Group Head of the Nuclear Medicine Units at Humanitas University and Cancer Center in Italy. With a Ph.D. in Molecular Imaging and an impressive academic trajectory, she has contributed over 280 articles to peer-reviewed journals, earning an H-index of 31. Her research focuses on oncological imaging, PET/CT, and molecular imaging, with significant contributions to both clinical practice and scientific knowledge. Dr. Evangelista has held key leadership positions, including Editor-in-Chief of the Clinical and Translational Imaging Journal and Leader of the EANM Women Empowerment Task Force. She is also a recipient of numerous national and international awards and grants. Known for her global collaborations and extensive involvement in professional societies, Dr. Evangelista is a leading figure in advancing the field of Nuclear Medicine. Profile Scopus Profile ORCID Profile Education Dr. Laura Evangelista has an extensive and well-rounded educational background in the field of Nuclear Medicine and Molecular Imaging. She earned her medical degree from the University of Napoli “Federico II” in 2004, followed by a specialization in Nuclear Medicine in 2009 from the same institution, where she excelled with honors. In 2012, she completed her PhD in Molecular Imaging, further solidifying her expertise in the field. Dr. Evangelista also pursued advanced training in health management and technology assessment, obtaining a Master in Health Technology Assessment (HTA) from the University Cattolica of Rome in 2016 and a Master in Health Management from the University of Naples Federico II in 2022. Her education is complemented by international exposure, including a research visit to the Mayo Clinic and an observership at the Breast Cancer Centre of Memorial Sloan Kettering in New York, enhancing her knowledge and skills in oncological imaging. Professional Experience Dr. Laura Evangelista is a distinguished expert in Nuclear Medicine, currently serving as an Extraordinary Professor and Group Head of the Nuclear Medicine Units at Humanitas University and Cancer Center. With a career spanning over a decade, she has held significant academic and clinical roles, including Associate and Assistant Professorships at the University of Padua. Dr. Evangelista’s expertise is deeply rooted in oncology and cardiology imaging, with a particular focus on PET/CT, SPECT, and radiometabolic therapy. She has also contributed to research on boron neutron capture therapy and molecular imaging. Throughout her career, Dr. Evangelista has maintained a strong presence in both academic and clinical settings, consistently advancing the field of Nuclear Medicine through her leadership, research, and dedication to improving patient outcomes. Her work is recognized globally, reflected in her numerous publications and leadership roles within prominent scientific organizations. Research Interest Dr. Laura Evangelista’s research interests lie primarily in the field of Nuclear Medicine, with a strong focus on molecular imaging, particularly in oncological applications. Her work has significantly contributed to the advancement of PET/CT imaging and scintigraphy in the detection and management of cancer. She is also deeply involved in the development and assessment of innovative imaging techniques, such as radiometabolic therapy, aimed at improving diagnostic accuracy and patient outcomes. Dr. Evangelista’s research extends to health technology assessment (HTA) and project management in healthcare, reflecting her interest in optimizing clinical practices and healthcare delivery. Additionally, her involvement in boron neutron capture therapy (BNCT) and cardiovascular imaging highlights her commitment to exploring multidisciplinary approaches within her field. Through her leadership roles and numerous publications, Dr. Evangelista continues to drive forward the integration of cutting-edge imaging technologies into clinical practice, enhancing the precision and efficacy of medical diagnostics. Research Skills Dr. Laura Evangelista possesses a robust set of research skills, honed through years of experience in Nuclear Medicine and molecular imaging. Her expertise encompasses advanced imaging techniques such as PET/CT, SPECT, and scintigraphy, particularly in oncology and cardiology. She is proficient in project management, as evidenced by her leadership roles in various research initiatives and her ability to secure competitive national and international grants. Dr. Evangelista’s analytical skills are reflected in her extensive publication record, with over 280 peer-reviewed articles, and her contributions to the development of health technology assessments. Additionally, she is skilled in statistical analysis, utilizing tools like SPSS and STATA, and is well-versed in meta-analysis techniques. Her collaborative work with international teams and her roles on editorial boards further highlight her capacity to lead and innovate in research, making her a distinguished figure in her field. Award and Recognition Dr. Laura Evangelista is a distinguished figure in Nuclear Medicine, known for her profound contributions to the field. She has published over 280 peer-reviewed articles, earning an H-index of 31, reflecting her significant research impact. Dr. Evangelista has received numerous awards from the Italian Association of Nuclear Medicine and secured both national and international grants, underscoring her research excellence. Her leadership roles are equally impressive, including serving as Editor-in-Chief of the Clinical and Translational Imaging Journal and leading the European Association of Nuclear Medicine (EANM) Women Empowerment Task Force. Dr. Evangelista has also played a pivotal role in organizing and speaking at over 200 national and international conferences, further establishing her as a key influencer in her field. Her work continues to shape the future of Nuclear Medicine, making her a well-recognized and highly respected professional in the global scientific community. Conclusion Dr. Laura Evangelista’s extensive contributions to Nuclear Medicine, combined with her leadership roles and recognition in the field, make her a strong candidate for the Best Researcher Award. Her research impact, coupled with her commitment to advancing the field, positions her well for this accolade. Publication Top Notes Title: Update on Rheumatic Diseases in Clinical Practice: Recent Concepts and Developments Authors: Giraudo, C., Sudol-Szopinska, I., Fichera, G., Guglielmi, G., Rennie, W. Year: 2024 Journal: Radiologic Clinics of North America Volume: 62 Issue: 5 Pages: 725–738 Title: Non-palpable Pulmonary Nodules and Uniportal-VATS: Radio-guided Localization (ROLL) Experience of a Lung Multidisciplinary Team Authors: Aricò, D., Macrì, P., Bambaci, M., Evangelista, L., Gebbia, V. Year: 2024 Journal: Anticancer Research Volume: 44 Issue: 8 Pages: 3507–3514 Title: [99mTc]Tc-sestamibi for the differential diagnosis of renal masses: a study protocol Authors: Urso, L., Evangelista, L., Giannarini, G., Filippi, L. Year: 2024 Journal: Clinical and Translational Imaging Volume: 12 Issue: 4 Pages: 383–386 Title: A Prospective Randomized Multicenter Study on the Impact of [18F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer Authors: Evangelista, L., Zattoni, F., Burei, M., De Salvo, G.L., Novara, G. Year: 2024 Journal: Journal of Nuclear Medicine Volume: 65 Issue: 7 Pages: 1013–1020 Title: Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers Authors: Asmundo, L., Rizzetto, F., Blake, M., Vanzulli, A., Catalano, O.A. Year: 2024 Journal: Journal of Clinical Medicine Volume: 13 Issue: 11 Article Number: 3281 Title: New target therapies in prostate cancer: from radioligand therapy, to PARP-inhibitors and immunotherapy Authors: Ceci, F., Airò Farulla, L.S., Bonatto, E., Borea, F., Zucali, P.A. Year: 2024 Journal: Quarterly Journal of Nuclear Medicine and Molecular Imaging Volume: 68 Issue: 2 Pages: 101–115 Title: The revolution of prostate cancer management with nuclear medicine: transforming diagnosis and treatment Authors: Evangelista, L., Ceci, F. Year: 2024 Journal: Quarterly Journal of Nuclear Medicine and Molecular Imaging Volume: 68 Issue: 2 Pages: 93–94 Title: Prostate cancer: nuclear medicine imaging in the biochemical recurrence and in oligometastatic disease Authors: Muraglia, L., Lopci, E., Jandric, J., Ceci, F., Evangelista, L. Year: 2024 Journal: Quarterly Journal of Nuclear Medicine and Molecular Imaging Volume: 68 Issue: 2 Pages: 95–100 Title: 18F-FET PET/CT in Calcifying Pseudoneoplasm of the Neuraxis: First Case Authors: Aricò, D., Giacoppo, G., Bambaci, M., Evangelista, L., Romano, A. Year: 2024 Journal: Clinical Nuclear Medicine Volume: 49 Issue: 6 Pages: E272–E273 Title: PARP-Targeted Radiotheranostics with Auger Electrons: An Updated Overview Authors: Filippi, L., Urso, L., Evangelista, L. Year: 2024 Journal: Current Issues in Molecular Biology Volume: 46 Issue: 4 Pages: 3039–3049 Laura Evangelista | Medicine Nuclear | Best Researcher Award
Dr. Laura Evangelista is a distinguished Nuclear Medicine physician and researcher, currently serving as an Extraordinary Professor and Group Head of the Nuclear Medicine Units at Humanitas University and Cancer Center in Italy. With a Ph.D. in Molecular Imaging and an impressive academic trajectory, she has contributed over 280 articles to peer-reviewed journals, earning an H-index of 31. Her research focuses on oncological imaging, PET/CT, and molecular imaging, with significant contributions to both clinical practice and scientific knowledge. Dr. Evangelista has held key leadership positions, including Editor-in-Chief of the Clinical and Translational Imaging Journal and Leader of the EANM Women Empowerment Task Force. She is also a recipient of numerous national and international awards and grants. Known for her global collaborations and extensive involvement in professional societies, Dr. Evangelista is a leading figure in advancing the field of Nuclear Medicine. Profile Scopus Profile ORCID Profile Education Dr. Laura Evangelista has an extensive and well-rounded educational background in the field of Nuclear Medicine and Molecular Imaging. She earned her medical degree from the University of Napoli “Federico II” in 2004, followed by a specialization in Nuclear Medicine in 2009 from the same institution, where she excelled with honors. In 2012, she completed her PhD in Molecular Imaging, further solidifying her expertise in the field. Dr. Evangelista also pursued advanced training in health management and technology assessment, obtaining a Master in Health Technology Assessment (HTA) from the University Cattolica of Rome in 2016 and a Master in Health Management from the University of Naples Federico II in 2022. Her education is complemented by international exposure, including a research visit to the Mayo Clinic and an observership at the Breast Cancer Centre of Memorial Sloan Kettering in New York, enhancing her knowledge and skills in oncological imaging. Professional Experience Dr. Laura Evangelista is a distinguished expert in Nuclear Medicine, currently serving as an Extraordinary Professor and Group Head of the Nuclear Medicine Units at Humanitas University and Cancer Center. With a career spanning over a decade, she has held significant academic and clinical roles, including Associate and Assistant Professorships at the University of Padua. Dr. Evangelista’s expertise is deeply rooted in oncology and cardiology imaging, with a particular focus on PET/CT, SPECT, and radiometabolic therapy. She has also contributed to research on boron neutron capture therapy and molecular imaging. Throughout her career, Dr. Evangelista has maintained a strong presence in both academic and clinical settings, consistently advancing the field of Nuclear Medicine through her leadership, research, and dedication to improving patient outcomes. Her work is recognized globally, reflected in her numerous publications and leadership roles within prominent scientific organizations. Research Interest Dr. Laura Evangelista’s research interests lie primarily in the field of Nuclear Medicine, with a strong focus on molecular imaging, particularly in oncological applications. Her work has significantly contributed to the advancement of PET/CT imaging and scintigraphy in the detection and management of cancer. She is also deeply involved in the development and assessment of innovative imaging techniques, such as radiometabolic therapy, aimed at improving diagnostic accuracy and patient outcomes. Dr. Evangelista’s research extends to health technology assessment (HTA) and project management in healthcare, reflecting her interest in optimizing clinical practices and healthcare delivery. Additionally, her involvement in boron neutron capture therapy (BNCT) and cardiovascular imaging highlights her commitment to exploring multidisciplinary approaches within her field. Through her leadership roles and numerous publications, Dr. Evangelista continues to drive forward the integration of cutting-edge imaging technologies into clinical practice, enhancing the precision and efficacy of medical diagnostics. Research Skills Dr. Laura Evangelista possesses a robust set of research skills, honed through years of experience in Nuclear Medicine and molecular imaging. Her expertise encompasses advanced imaging techniques such as PET/CT, SPECT, and scintigraphy, particularly in oncology and cardiology. She is proficient in project management, as evidenced by her leadership roles in various research initiatives and her ability to secure competitive national and international grants. Dr. Evangelista’s analytical skills are reflected in her extensive publication record, with over 280 peer-reviewed articles, and her contributions to the development of health technology assessments. Additionally, she is skilled in statistical analysis, utilizing tools like SPSS and STATA, and is well-versed in meta-analysis techniques. Her collaborative work with international teams and her roles on editorial boards further highlight her capacity to lead and innovate in research, making her a distinguished figure in her field. Award and Recognition Dr. Laura Evangelista is a distinguished figure in Nuclear Medicine, known for her profound contributions to the field. She has published over 280 peer-reviewed articles, earning an H-index of 31, reflecting her significant research impact. Dr. Evangelista has received numerous awards from the Italian Association of Nuclear Medicine and secured both national and international grants, underscoring her research excellence. Her leadership roles are equally impressive, including serving as Editor-in-Chief of the Clinical and Translational Imaging Journal and leading the European Association of Nuclear Medicine (EANM) Women Empowerment Task Force. Dr. Evangelista has also played a pivotal role in organizing and speaking at over 200 national and international conferences, further establishing her as a key influencer in her field. Her work continues to shape the future of Nuclear Medicine, making her a well-recognized and highly respected professional in the global scientific community. Conclusion Dr. Laura Evangelista’s extensive contributions to Nuclear Medicine, combined with her leadership roles and recognition in the field, make her a strong candidate for the Best Researcher Award. Her research impact, coupled with her commitment to advancing the field, positions her well for this accolade. Publication Top Notes Title: Update on Rheumatic Diseases in Clinical Practice: Recent Concepts and Developments Authors: Giraudo, C., Sudol-Szopinska, I., Fichera, G., Guglielmi, G., Rennie, W. Year: 2024 Journal: Radiologic Clinics of North America Volume: 62 Issue: 5 Pages: 725–738 Title: Non-palpable Pulmonary Nodules and Uniportal-VATS: Radio-guided Localization (ROLL) Experience of a Lung Multidisciplinary Team Authors: Aricò, D., Macrì, P., Bambaci, M., Evangelista, L., Gebbia, V. Year: 2024 Journal: Anticancer Research Volume: 44 Issue: 8 Pages: 3507–3514 Title: [99mTc]Tc-sestamibi for the differential diagnosis of renal masses: a study protocol Authors: Urso, L., Evangelista, L., Giannarini, G., Filippi, L. Year: 2024 Journal: Clinical and Translational Imaging Volume: 12 Issue: 4 Pages: 383–386 Title: A Prospective Randomized Multicenter Study on the Impact of [18F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer Authors: Evangelista, L., Zattoni, F., Burei, M., De Salvo, G.L., Novara, G. Year: 2024 Journal: Journal of Nuclear Medicine Volume: 65 Issue: 7 Pages: 1013–1020 Title: Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers Authors: Asmundo, L., Rizzetto, F., Blake, M., Vanzulli, A., Catalano, O.A. Year: 2024 Journal: Journal of Clinical Medicine Volume: 13 Issue: 11 Article Number: 3281 Title: New target therapies in prostate cancer: from radioligand therapy, to PARP-inhibitors and immunotherapy Authors: Ceci, F., Airò Farulla, L.S., Bonatto, E., Borea, F., Zucali, P.A. Year: 2024 Journal: Quarterly Journal of Nuclear Medicine and Molecular Imaging Volume: 68 Issue: 2 Pages: 101–115 Title: The revolution of prostate cancer management with nuclear medicine: transforming diagnosis and treatment Authors: Evangelista, L., Ceci, F. Year: 2024 Journal: Quarterly Journal of Nuclear Medicine and Molecular Imaging Volume: 68 Issue: 2 Pages: 93–94 Title: Prostate cancer: nuclear medicine imaging in the biochemical recurrence and in oligometastatic disease Authors: Muraglia, L., Lopci, E., Jandric, J., Ceci, F., Evangelista, L. Year: 2024 Journal: Quarterly Journal of Nuclear Medicine and Molecular Imaging Volume: 68 Issue: 2 Pages: 95–100 Title: 18F-FET PET/CT in Calcifying Pseudoneoplasm of the Neuraxis: First Case Authors: Aricò, D., Giacoppo, G., Bambaci, M., Evangelista, L., Romano, A. Year: 2024 Journal: Clinical Nuclear Medicine Volume: 49 Issue: 6 Pages: E272–E273 Title: PARP-Targeted Radiotheranostics with Auger Electrons: An Updated Overview Authors: Filippi, L., Urso, L., Evangelista, L. Year: 2024 Journal: Current Issues in Molecular Biology Volume: 46 Issue: 4 Pages: 3039–3049
Dr. Laura Evangelista has an extensive and well-rounded educational background in the field of Nuclear Medicine and Molecular Imaging. She earned her medical degree from the University of Napoli “Federico II” in 2004, followed by a specialization in Nuclear Medicine in 2009 from the same institution, where she excelled with honors. In 2012, she completed her PhD in Molecular Imaging, further solidifying her expertise in the field. Dr. Evangelista also pursued advanced training in health management and technology assessment, obtaining a Master in Health Technology Assessment (HTA) from the University Cattolica of Rome in 2016 and a Master in Health Management from the University of Naples Federico II in 2022. Her education is complemented by international exposure, including a research visit to the Mayo Clinic and an observership at the Breast Cancer Centre of Memorial Sloan Kettering in New York, enhancing her knowledge and skills in oncological imaging.
Dr. Laura Evangelista is a distinguished expert in Nuclear Medicine, currently serving as an Extraordinary Professor and Group Head of the Nuclear Medicine Units at Humanitas University and Cancer Center. With a career spanning over a decade, she has held significant academic and clinical roles, including Associate and Assistant Professorships at the University of Padua. Dr. Evangelista’s expertise is deeply rooted in oncology and cardiology imaging, with a particular focus on PET/CT, SPECT, and radiometabolic therapy. She has also contributed to research on boron neutron capture therapy and molecular imaging. Throughout her career, Dr. Evangelista has maintained a strong presence in both academic and clinical settings, consistently advancing the field of Nuclear Medicine through her leadership, research, and dedication to improving patient outcomes. Her work is recognized globally, reflected in her numerous publications and leadership roles within prominent scientific organizations. Research Interest Dr. Laura Evangelista’s research interests lie primarily in the field of Nuclear Medicine, with a strong focus on molecular imaging, particularly in oncological applications. Her work has significantly contributed to the advancement of PET/CT imaging and scintigraphy in the detection and management of cancer. She is also deeply involved in the development and assessment of innovative imaging techniques, such as radiometabolic therapy, aimed at improving diagnostic accuracy and patient outcomes. Dr. Evangelista’s research extends to health technology assessment (HTA) and project management in healthcare, reflecting her interest in optimizing clinical practices and healthcare delivery. Additionally, her involvement in boron neutron capture therapy (BNCT) and cardiovascular imaging highlights her commitment to exploring multidisciplinary approaches within her field. Through her leadership roles and numerous publications, Dr. Evangelista continues to drive forward the integration of cutting-edge imaging technologies into clinical practice, enhancing the precision and efficacy of medical diagnostics. Research Skills Dr. Laura Evangelista possesses a robust set of research skills, honed through years of experience in Nuclear Medicine and molecular imaging. Her expertise encompasses advanced imaging techniques such as PET/CT, SPECT, and scintigraphy, particularly in oncology and cardiology. She is proficient in project management, as evidenced by her leadership roles in various research initiatives and her ability to secure competitive national and international grants. Dr. Evangelista’s analytical skills are reflected in her extensive publication record, with over 280 peer-reviewed articles, and her contributions to the development of health technology assessments. Additionally, she is skilled in statistical analysis, utilizing tools like SPSS and STATA, and is well-versed in meta-analysis techniques. Her collaborative work with international teams and her roles on editorial boards further highlight her capacity to lead and innovate in research, making her a distinguished figure in her field. Award and Recognition Dr. Laura Evangelista is a distinguished figure in Nuclear Medicine, known for her profound contributions to the field. She has published over 280 peer-reviewed articles, earning an H-index of 31, reflecting her significant research impact. Dr. Evangelista has received numerous awards from the Italian Association of Nuclear Medicine and secured both national and international grants, underscoring her research excellence. Her leadership roles are equally impressive, including serving as Editor-in-Chief of the Clinical and Translational Imaging Journal and leading the European Association of Nuclear Medicine (EANM) Women Empowerment Task Force. Dr. Evangelista has also played a pivotal role in organizing and speaking at over 200 national and international conferences, further establishing her as a key influencer in her field. Her work continues to shape the future of Nuclear Medicine, making her a well-recognized and highly respected professional in the global scientific community. Conclusion Dr. Laura Evangelista’s extensive contributions to Nuclear Medicine, combined with her leadership roles and recognition in the field, make her a strong candidate for the Best Researcher Award. Her research impact, coupled with her commitment to advancing the field, positions her well for this accolade. Publication Top Notes Title: Update on Rheumatic Diseases in Clinical Practice: Recent Concepts and Developments Authors: Giraudo, C., Sudol-Szopinska, I., Fichera, G., Guglielmi, G., Rennie, W. Year: 2024 Journal: Radiologic Clinics of North America Volume: 62 Issue: 5 Pages: 725–738 Title: Non-palpable Pulmonary Nodules and Uniportal-VATS: Radio-guided Localization (ROLL) Experience of a Lung Multidisciplinary Team Authors: Aricò, D., Macrì, P., Bambaci, M., Evangelista, L., Gebbia, V. Year: 2024 Journal: Anticancer Research Volume: 44 Issue: 8 Pages: 3507–3514 Title: [99mTc]Tc-sestamibi for the differential diagnosis of renal masses: a study protocol Authors: Urso, L., Evangelista, L., Giannarini, G., Filippi, L. Year: 2024 Journal: Clinical and Translational Imaging Volume: 12 Issue: 4 Pages: 383–386 Title: A Prospective Randomized Multicenter Study on the Impact of [18F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer Authors: Evangelista, L., Zattoni, F., Burei, M., De Salvo, G.L., Novara, G. Year: 2024 Journal: Journal of Nuclear Medicine Volume: 65 Issue: 7 Pages: 1013–1020 Title: Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers Authors: Asmundo, L., Rizzetto, F., Blake, M., Vanzulli, A., Catalano, O.A. Year: 2024 Journal: Journal of Clinical Medicine Volume: 13 Issue: 11 Article Number: 3281 Title: New target therapies in prostate cancer: from radioligand therapy, to PARP-inhibitors and immunotherapy Authors: Ceci, F., Airò Farulla, L.S., Bonatto, E., Borea, F., Zucali, P.A. Year: 2024 Journal: Quarterly Journal of Nuclear Medicine and Molecular Imaging Volume: 68 Issue: 2 Pages: 101–115 Title: The revolution of prostate cancer management with nuclear medicine: transforming diagnosis and treatment Authors: Evangelista, L., Ceci, F. Year: 2024 Journal: Quarterly Journal of Nuclear Medicine and Molecular Imaging Volume: 68 Issue: 2 Pages: 93–94 Title: Prostate cancer: nuclear medicine imaging in the biochemical recurrence and in oligometastatic disease Authors: Muraglia, L., Lopci, E., Jandric, J., Ceci, F., Evangelista, L. Year: 2024 Journal: Quarterly Journal of Nuclear Medicine and Molecular Imaging Volume: 68 Issue: 2 Pages: 95–100 Title: 18F-FET PET/CT in Calcifying Pseudoneoplasm of the Neuraxis: First Case Authors: Aricò, D., Giacoppo, G., Bambaci, M., Evangelista, L., Romano, A. Year: 2024 Journal: Clinical Nuclear Medicine Volume: 49 Issue: 6 Pages: E272–E273 Title: PARP-Targeted Radiotheranostics with Auger Electrons: An Updated Overview Authors: Filippi, L., Urso, L., Evangelista, L. Year: 2024 Journal: Current Issues in Molecular Biology Volume: 46 Issue: 4 Pages: 3039–3049
Title: Update on Rheumatic Diseases in Clinical Practice: Recent Concepts and Developments Authors: Giraudo, C., Sudol-Szopinska, I., Fichera, G., Guglielmi, G., Rennie, W. Year: 2024 Journal: Radiologic Clinics of North America Volume: 62 Issue: 5 Pages: 725–738 Title: Non-palpable Pulmonary Nodules and Uniportal-VATS: Radio-guided Localization (ROLL) Experience of a Lung Multidisciplinary Team Authors: Aricò, D., Macrì, P., Bambaci, M., Evangelista, L., Gebbia, V. Year: 2024 Journal: Anticancer Research Volume: 44 Issue: 8 Pages: 3507–3514 Title: [99mTc]Tc-sestamibi for the differential diagnosis of renal masses: a study protocol Authors: Urso, L., Evangelista, L., Giannarini, G., Filippi, L. Year: 2024 Journal: Clinical and Translational Imaging Volume: 12 Issue: 4 Pages: 383–386 Title: A Prospective Randomized Multicenter Study on the Impact of [18F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer Authors: Evangelista, L., Zattoni, F., Burei, M., De Salvo, G.L., Novara, G. Year: 2024 Journal: Journal of Nuclear Medicine Volume: 65 Issue: 7 Pages: 1013–1020 Title: Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers Authors: Asmundo, L., Rizzetto, F., Blake, M., Vanzulli, A., Catalano, O.A. Year: 2024 Journal: Journal of Clinical Medicine Volume: 13 Issue: 11 Article Number: 3281 Title: New target therapies in prostate cancer: from radioligand therapy, to PARP-inhibitors and immunotherapy Authors: Ceci, F., Airò Farulla, L.S., Bonatto, E., Borea, F., Zucali, P.A. Year: 2024 Journal: Quarterly Journal of Nuclear Medicine and Molecular Imaging Volume: 68 Issue: 2 Pages: 101–115 Title: The revolution of prostate cancer management with nuclear medicine: transforming diagnosis and treatment Authors: Evangelista, L., Ceci, F. Year: 2024 Journal: Quarterly Journal of Nuclear Medicine and Molecular Imaging Volume: 68 Issue: 2 Pages: 93–94 Title: Prostate cancer: nuclear medicine imaging in the biochemical recurrence and in oligometastatic disease Authors: Muraglia, L., Lopci, E., Jandric, J., Ceci, F., Evangelista, L. Year: 2024 Journal: Quarterly Journal of Nuclear Medicine and Molecular Imaging Volume: 68 Issue: 2 Pages: 95–100 Title: 18F-FET PET/CT in Calcifying Pseudoneoplasm of the Neuraxis: First Case Authors: Aricò, D., Giacoppo, G., Bambaci, M., Evangelista, L., Romano, A. Year: 2024 Journal: Clinical Nuclear Medicine Volume: 49 Issue: 6 Pages: E272–E273 Title: PARP-Targeted Radiotheranostics with Auger Electrons: An Updated Overview Authors: Filippi, L., Urso, L., Evangelista, L. Year: 2024 Journal: Current Issues in Molecular Biology Volume: 46 Issue: 4 Pages: 3039–3049